Aug 23 2017
12:00 AM
William Garvin, Shareholder in the firm's FDA & Biotechnology section, and Michael Strazzella, Practice Group Leader of Buchanan's Federal Government Relations practice and head of Buchanan's Washington D.C. office, presented "2017-2018 Federal Update Forecast" at Specialty Pharma Association's Regulatory Workshop.
Professionals
Related Services & Industries
Related Offices